PMC:7445716 / 81915-82843
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T770 | 156-164 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T771 | 176-179 | Disease | denotes | GBS | http://purl.obolibrary.org/obo/MONDO_0016218 |
| T772 | 337-345 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T773 | 482-490 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T774 | 495-498 | Disease | denotes | GBS | http://purl.obolibrary.org/obo/MONDO_0016218 |
| T775 | 624-628 | Disease | denotes | CIDP | http://purl.obolibrary.org/obo/MONDO_0006702|http://purl.obolibrary.org/obo/MONDO_0007691 |
| T777 | 790-793 | Disease | denotes | GBS | http://purl.obolibrary.org/obo/MONDO_0016218 |
| T778 | 873-876 | Disease | denotes | GBS | http://purl.obolibrary.org/obo/MONDO_0016218 |
| T779 | 883-891 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T723 | 51-52 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T724 | 660-661 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1252 | 67-75 | Species | denotes | patient | Tax:9606 |
| 1253 | 155-163 | Disease | denotes | COVID-1 | MESH:C000657245 |
| 1254 | 336-344 | Disease | denotes | COVID-1 | MESH:C000657245 |
| 1255 | 481-489 | Disease | denotes | COVID-1 | MESH:C000657245 |
| 1256 | 623-627 | Disease | denotes | CID | MESH:D020277 |
| 1257 | 882-890 | Disease | denotes | COVID-1 | MESH:C000657245 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T481 | 0-180 | Sentence | denotes | Major strengths of our review are the inclusion of a high number of patients, together with an in-depth analysis of the clinical and diagnostic features of COVID-19-associated GBS. |
| T482 | 181-364 | Sentence | denotes | We are aware that selection bias might have occurred, given that most reported cases to date have been described mostly in Europe (47 out of 73) and during COVID-19 highest spreading. |
| T483 | 365-524 | Sentence | denotes | Therefore, future extensive epidemiological studies are necessary to ascertain the nature of the association between COVID-19 and GBS (causal or coincidental). |
| T484 | 525-693 | Sentence | denotes | Moreover, we cannot exclude the possibility that at least some of the cases represent instances of CIDP, given the frequent absence of a follow-up longer than 2 months. |
| T485 | 694-928 | Sentence | denotes | On another issue, the low but possible evidence of an epidemiological link between vaccines and GBS development [57, 58] should aware the clinicians of the possible occurrence of GBS after COVID-19 vaccination in the long-term future. |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1209 | 156-164 | SP_7 | denotes | COVID-19 |
| T1210 | 337-345 | SP_7 | denotes | COVID-19 |
| T1211 | 482-490 | SP_7 | denotes | COVID-19 |
| T1212 | 883-891 | SP_7 | denotes | COVID-19 |
| T52689 | 156-164 | SP_7 | denotes | COVID-19 |
| T93654 | 337-345 | SP_7 | denotes | COVID-19 |
| T6953 | 482-490 | SP_7 | denotes | COVID-19 |
| T26779 | 883-891 | SP_7 | denotes | COVID-19 |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32840686-31541214-63205875 | 806-808 | 31541214 | denotes | [5 |
| 32840686-26948435-63205876 | 810-812 | 26948435 | denotes | 5 |